These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24225910)

  • 41. Influence of myopic macular degeneration severity on treatment outcomes with intravitreal aflibercept in the MYRROR study.
    Cheung CMG; Ohno-Matsui K; Wong TY; Li T; Asmus F; Leal S;
    Acta Ophthalmol; 2019 Aug; 97(5):e729-e735. PubMed ID: 30690902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    Takasago Y; Shiragami C; Kobayashi M; Osaka R; Ono A; Yamashita A; Tsujikawa A; Hirooka K
    Retina; 2019 Feb; 39(2):296-302. PubMed ID: 29190232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing ranibizumab with bevacizumab.
    Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
    Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
    [No Abstract]   [Full Text] [Related]  

  • 44. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
    Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
    Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept at fixed intervals as per UK licence.
    Ozturk M; Harris ML; Nguyen V; Barthelmes D; Gillies MC; Mehta H
    Clin Exp Ophthalmol; 2018 May; 46(4):407-411. PubMed ID: 29044979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal Ziv-Aflibercept: A Comprehensive Review.
    Barmas-Alamdari D; D'Souza HS; Kapoor KG; Wagner AL
    Semin Ophthalmol; 2019; 34(6):420-435. PubMed ID: 31314638
    [No Abstract]   [Full Text] [Related]  

  • 47. Choroidal Thickness Changes After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
    Minnella AM; Federici M; Falsini B; Barbano L; Gambini G; Lanza A; Caporossi A; Savastano MC
    BioDrugs; 2016 Aug; 30(4):353-9. PubMed ID: 27189458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting.
    Eleftheriadou M; Vazquez-Alfageme C; Citu CM; Crosby-Nwaobi R; Sivaprasad S; Hykin P; Hamilton RD; Patel PJ
    Am J Ophthalmol; 2017 Feb; 174():160-168. PubMed ID: 27746298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results.
    Taipale C; Lindholm JM; Kaarniranta K; Tuuminen R
    Adv Ther; 2020 May; 37(5):2256-2266. PubMed ID: 32277343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macular hemorrhage in neovascular age-related macular degeneration after stabilization with antiangiogenic therapy.
    Levine JP; Marcus I; Sorenson JA; Spaide RF; Cooney MJ; Freund KB
    Retina; 2009 Sep; 29(8):1074-9. PubMed ID: 19734761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Outcomes in Patients with Neovascular Age-Related Macular Degeneration Who Maintain Dry Macula after Three Monthly Ranibizumab Injections.
    Kim KM; Kim JH; Chang YS; Kim JW; Kim CG
    Semin Ophthalmol; 2018; 33(3):371-376. PubMed ID: 27960586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration.
    Khurana RN; Kunimoto D; Yoon YH; Wykoff CC; Chang A; Maturi RK; Agostini H; Souied E; Chow DR; Lotery AJ; Ohji M; Bandello F; Belfort R; Li XY; Jiao J; Le G; Kim K; Schmidt W; Hashad Y;
    Ophthalmology; 2021 Jul; 128(7):1027-1038. PubMed ID: 33221326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical research on intravitreal injection of bevacizumab in the treatment of macula lutea and retinal edema of ocular fundus disease.
    Yan Y; Wang T; Cao J; Wang M; Li F
    Pak J Pharm Sci; 2015 Jul; 28(4 Suppl):1481-4. PubMed ID: 26431660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Boiko EV; Maltsev DS
    Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability.
    Hata M; Oishi A; Tsujikawa A; Yamashiro K; Miyake M; Ooto S; Tamura H; Nakanishi H; Takahashi A; Yoshikawa M; Yoshimura N
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):7874-80. PubMed ID: 25395483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum concentration of vascular endothelial growth factor after bilateral intravitreal injection of bevacizumab.
    Wang D; Choi KS; Lee SJ
    Korean J Ophthalmol; 2014 Feb; 28(1):32-8. PubMed ID: 24505199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of intravitreal aflibercept in patients with exudative age-related macular degeneration.
    Dolar-Szczasny J; swiEch-zuBilewicz A; Mackiewicz J
    Klin Oczna; 2016 Sep; 117(4):221-224. PubMed ID: 29727106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 59. Two-Year Outcomes of a Treat-and-Extend Regimen Using Intravitreal Aflibercept Injections for Typical Age-Related Macular Degeneration.
    Ito A; Matsumoto H; Morimoto M; Mimura K; Akiyama H
    Ophthalmologica; 2017; 238(4):236-242. PubMed ID: 28898873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantification of error in optical coherence tomography central macular thickness measurement in wet age-related macular degeneration.
    Ghazi NG; Kirk T; Allam S; Yan G
    Am J Ophthalmol; 2009 Jul; 148(1):90-6.e2. PubMed ID: 19403111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.